Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Total Non-Current Liabilities of $1.24 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 36.5% from $1.95 million a year earlier and down 3.7% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Total Non-Current Liabilities came in at $334 million, up 12.1% from FY2025.
- Annual Total Non-Current Liabilities has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 21.9% (FY2021 to FY2026).
- In prior fiscal years, Dr Reddys Laboratories' Total Non-Current Liabilities was $298 million in FY2025 (+125.8%), $132 million in FY2024 (+116.4%), $61 million in FY2023 (-44.0%) and $109 million in FY2022 (-12.1%).
- Quarterly Total Non-Current Liabilities has run from a low of $638,189 in fiscal Q2 2023 to a high of $331.97 million in fiscal Q4 2026 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in five of the last eight quarters, with growth averaging 42.9%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q1 2026, with growth of 168.9%; the weakest was fiscal Q4 2023, with a decline of 44.1%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $1.29 million (Q1 2027), $331.97 million (Q4 2026) and $1.17 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 1.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.24 Mn |
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 331.97 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 297.30 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 730,968.78 |
| Mar 31, 2024 | 131.05 Mn |
| Dec 31, 2023 | 741,172.72 |
| Sep 30, 2023 | 709,194.30 |
| Jun 30, 2023 | 731,035.12 |
| Mar 31, 2023 | 61.12 Mn |
| Dec 31, 2022 | 688,114.12 |
| Sep 30, 2022 | 638,188.72 |
| Jun 30, 2022 | 697,099.92 |
| Mar 31, 2022 | 109.26 Mn |
| Dec 31, 2021 | 779,243.16 |
API Access
Dr Reddys Laboratories Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();